Get 1 week of unlimited access
Class Notes (1,034,535)
US (406,289)
UMN (3,932)
HMED (18)
Lecture 18

HMED 3075 Lecture Notes - Lecture 18: Pharmacogenomics, Pharmacogenetics, Personalized MedicinePremium

2 pages39 viewsFall 2016

Department
History of Medicine
Course Code
HMED 3075
Professor
Tobbell D
Lecture
18

This preview shows half of the first page. to view the full 2 pages of the document.
HMED 3075 Lecture Notes on 11/28/16 Market Race
o Lecture: Pharmacogenomic Innovations
o Reading:
Deborah Bolnick et al., “The Science and Business of Genetic Ancestry
Testing.” Science (Oct. 19, 2007) 318: 399-400.
Alondra Nelson, “Bio Science: Genealogy Testing and the Pursuit of African Ancestry”
Pharmacogenomics as Genomic Innovation:
Pharmacogenetics: the study of how gees affet a perso’s respose to drugs
Pharmacogenomics: screening the genome for pharmacogenetic reactions
Physicians understand that people have different reactions to the treatments they
receive
Pharmacogenomics and Personalized Medicine:
Pharmaceutical companies became intensely interested in pharmacogenomics drug
development in the late 1990s
Companies instead develop drugs targeted to these specific genetic variants
o Removes uncertainty from the drug development process
o Reduces potential for adverse drug reactions
o Reduces drug development costs by shortening length of trials and thus time to
FDA approval
o Will reduce health care expenditures on prescription drugs
Accessing Pharmacogenomic Information:
Information available on the FDA website and from the drug label
Companies like GeneSight offers pharmacogenetics testing that help determine drugs to
prescribe
Herceptin: A Pharmacogenomic Drug
Poster drug for personalized medicine
find more resources at oneclass.com
find more resources at oneclass.com
You're Reading a Preview

Unlock to view full version

Subscribers Only

Loved by over 2.2 million students

Over 90% improved by at least one letter grade.